A phase II study of cell cycle inhibitor UCN-01 in patients with metastatic melanoma: a California Cancer Consortium trial

By Li Tianhong  

Investigational New Drugs, Vol. 30, Iss. 2, 2012-04 ,pp. : 741-748

Springer Publishing Company

Access to resources Recommend Favorite

Combination gemcitabine + cisplatin therapy for recurrent ovarian cancer

By  

Inpharma, Vol. 1, Iss. 1376, 2003-01 ,pp. : 14-14

Adis International

Access to resources Recommend Favorite

A randomized phase II trial of interleukin-2 in combination with four different doses of bryostatin-1 in patients with renal cell carcinoma

By Peterson Amy   Harlin Helena   Karrison Theodore   Vogelzang Nicholas   Knost James   Kugler John   Lester Eric   Vokes Everett   Gajewski Thomas   Stadler Walter  

Investigational New Drugs, Vol. 24, Iss. 2, 2006-03 ,pp. : 141-149

Springer Publishing Company

Access to resources Recommend Favorite

A randomized phase II evaluation of bryostatin-1 (NSC #339555) in persistent or recurrent squamous cell carcinoma of the cervix: A Gynecologic Oncology Group Study

By Armstrong Deborah K.   Blessing John A.   Rader Janet   Sorosky Joel I.  

Investigational New Drugs, Vol. 21, Iss. 4, 2003-11 ,pp. : 453-457

Springer Publishing Company

Access to resources Recommend Favorite

A phase 1/pharmacokinetic study of sunitinib in combination with highly active antiretroviral therapy in human immunodeficiency virus-positive patients with cancer: AIDS Malignancy Consortium trial AMC 061

By Rudek Michelle A.   Moore Page C.   Mitsuyasu Ronald T.   Dezube Bruce J.   Aboulafia David   Gerecitano John   Sullivan Ryan   Cianfrocca Mary E.   Henry David H.   Ratner Lee   Haigentz Missak   Dowlati Afshin   Little Richard F.   Ivy Susan Percy   Deeken John F.  

Cancer, Vol. 120, Iss. 8, 2014-04 ,pp. : 1194-1202

Blackwell Publishing

Access to resources Recommend Favorite